Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Doveil

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 1, 1986
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)]M G Bernengo, G C Doveil, F Lisa, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevanceG C Doveil, M T Fierro, M Novelli, et al.
Melanoma Research|June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot studyM G Bernengo, G C Doveil, M Bertero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological featuresM G Bernengo, P Quaglino, M Novelli, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 1, 1986
[Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)]M G Bernengo, G C Doveil, F Lisa, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevanceG C Doveil, M T Fierro, M Novelli, et al.
Melanoma Research|June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot studyM G Bernengo, G C Doveil, M Bertero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological featuresM G Bernengo, P Quaglino, M Novelli, et al.
Pageof 2